Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended March 31, 2025 of $0.049 Per Unit GlobeNewswire May 08, 2025 ATHENS, Greece, May 08, 2025 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a […]
Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire May 08, 2025 Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal Hyperplasia to Initiate with Uncompromising
(NASDAQ:VRNS), MIAMI, May 08, 2025 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced its participation at the following upcoming conferences: The J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference, May 13 – 15, in Boston. The presentation is scheduled for May 15 at 8:40 a.m. ET. The
Root, Inc. to Participate in the 2025 Wells Fargo Financial Services Investor Conference GlobeNewswire May 08, 2025 COLUMBUS, Ohio, May 08, 2025 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its participation in the 2025 Wells Fargo Financial Services Investor
(NASDAQ:ORGO), CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025
Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results GlobeNewswire May 08, 2025 Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 million as
Profound Medical Announces First Quarter 2025 Financial Results GlobeNewswire May 08, 2025 TORONTO, May 08, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the first
Magnite to Participate in Upcoming Financial Conferences GlobeNewswire May 08, 2025 NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host in-person investor meetings at the following financial conferences: 20th Annual Needham Technology, Media and Consumer
Longeveron(R) Announces First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire May 08, 2025 Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric disease and orphan-designated indication, has reached approximately 95% enrollment and is expected to complete enrollment in the second quarter of 2025 Laromestrocel Biological License Application (BLA)
Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire May 08, 2025 Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal Hyperplasia to Initiate with Uncompromising